Benefits and adverses effects of testosterone therapy

Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
bookPart
Data de publicação
2017
DOI
Scopus
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER INTERNATIONAL PUBLISHING
Autores
Citação
Costa, E. M. F.; Amato, L. G. L.; Silveira, L. F. G.. Benefits and adverses effects of testosterone therapy. In: . TESTOSTERONE: FROM BASIC TO CLINICAL ASPECTS: SPRINGER INTERNATIONAL PUBLISHING, 2017. p.253-269.
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Testosterone plays an essential role in several aspects of men’s health. The main indication for testosterone treatment is in men with a confirmed diagnosis of hypogonadism, signs of androgen deficiency, and low serum testosterone levels. Other possible indications include constitutional delay of growth and puberty, men with sexual dysfunction, female to male transgender persons, androgen deficiency in the aging male, hypogonadism secondary to drugs, and chronic illness. Common drug-related adverse events include increase in hematocrit, acne, breast tenderness, gynecomastia, and exogenous testosterone can lead to a state of transitory infertility. It is not recommended to begin testosterone replacement therapy in men with untreated severe obstructive sleep apnea or with benign prostatic hypertrophy. The effects of testosterone on lipid metabolism and cardiovascular risk remain uncertain. In each situation the testosterone replacement brings specific benefits but the overall goals of therapy are to establish and maintain secondary sexual characteristics, sexual function, sense of well-being, and to improve body composition, muscle mass and strength, bone mineral density, and quality of life. © Springer International Publishing Switzerland 2017.
Palavras-chave
Androgen deficiency, Drug-related adverse effects, Hypogonadism, Testosterone replacement benefits
URI
https://observatorio.fm.usp.br/handle/OPI/51245
Referências
  1. Biason-Lauber, A., Control of sex development (2010) Best Pract Res Clin Endocrinol Metab, 24, pp. 163-186
  2. Petersen, C., Soder, O., The sertoli cell--a hormonal target and ‘super’ nurse for germ cells that determines testicular size (2006) Horm Res, 66, pp. 153-161
  3. Rey, R.A., Grinspon, R.P., Gottlieb, S., Pasqualini, T., Knoblovits, P., Aszpis, S., Pacenza, N., Campo, S.M., Male hypogonadism: An extended classification based on a developmental, endocrine physiology-based approach (2012) Andrology, 1, pp. 3-16
  4. Terasawa, E., Fernandez, D.L., Neurobiological mechanisms of the onset of puberty in primates (2001) Endocr Rev, 22, pp. 111-151
  5. Palmert, M.R., Boepple, P.A., Variation in the timing of puberty: Clinical spectrum and genetic investigation (2001) J Clin Endocrinol Metab, 86, pp. 2364-2368
  6. Patton, G.C., Viner, R., Pubertal transitions in health (2007) Lancet, 369, pp. 1130-1139
  7. Bhasin, S., Cunningham, G.R., Hayes, F.J., Matsumoto, A.M., Snyder, P.J., Swerdloff, R.S., Montori, V.M., Testosterone therapy in men with androgen deficiency syndromes: An Endocrine Society clinical practice guideline (2010) J Clin Endocrinol Metab, 95, pp. 2536-2559
  8. Basaria, S., Male hypogonadism (2014) Lancet, 383, p. 1250
  9. Wu, F.C., Tajar, A., Beynon, J.M., Pye, S.R., Silman, A.J., Finn, J.D., O’neill, T.W., Huhtaniemi, I.T., Identification of late-onset hypogonadism in middle-aged and elderly men (2010) N Engl J Med, 363, pp. 123-135
  10. Zitzmann, M., Faber, S., Nieschlag, E., Association of specific symptoms and metabolic risks with serum testosterone in older men (2006) J Clin Endocrinol Metab, 91, pp. 4335-4343
  11. Hall, S.A., Esche, G.R., Araujo, A.B., Travison, T.G., Clark, R.V., Williams, R.E., Mc Kinlay, J.B., Correlates of low testosterone and symptomatic androgen deficiency in a population-based sample (2008) J Clin Endocrinol Metab, 93, pp. 3870-3877
  12. Kelleher, S., Conway, A.J., Handelsman, D.J., Blood testosterone threshold for androgen deficiency symptoms (2004) J Clin Endocrinol Metab, 89, pp. 3813-3817
  13. Silveira, L.F., Latronico, A.C., Approach to the patient with hypogonadotropic hypogonadism (2013) J Clin Endocrinol Metab, 98, pp. 1781-1788
  14. Palmert, M.R., Dunkel L. Clinical practice. Delayed puberty (2012) N Engl J Med, 366, pp. 443-453
  15. Gilsanz, V., Chalfant, J., Kalkwarf, H., Zemel, B., Lappe, J., Oberfield, S., Shepherd, J., Winer, K., Age at onset of puberty predicts bone mass in young adulthood (2011) J Pediatr, 158, pp. e101-102.. , 100-5. 105
  16. Dunkel, L., Quinton, R., Transition in endocrinology: Induction of puberty (2014) Eur J Endocrinol, 170, pp. R229-RR39
  17. Soliman, A.T., Khadir, M.M., Asfour, M., Testosterone treatment in adolescent boys with constitu-tional delay of growth and development (1995) Metabolism, 44, pp. 1013-1015
  18. Richman, R.A., Kirsch, L.R., Testosterone treatment in adolescent boys with constitutional delay in growth and development (1988) N Engl J Med, 319, pp. 1563-1567
  19. Viswanathan, V., Eugster, E.A., Etiology and treatment of hypogonadism in adolescents (2011) Pediatr Clin North Am, 58, pp. 1181-1200
  20. Mayo, A., Macintyre, H., Wallace, A.M., Ahmed, S.F., Transdermal testosterone application: Phar-macokinetics and effects on pubertal status, short-term growth, and bone turnover (2004) J Clin Endocrinol Metab, 89, pp. 681-687
  21. Lawaetz, J.G., Hagen, C.P., Mieritz, M.G., Blomberg Jensen, M., Petersen, J.H., Juul, A., Evaluation of 451 Danish boys with delayed puberty: Diagnostic use of a new puberty nomogram and effects of oral testosterone therapy (2015) J Clin Endocrinol Metab, 100, pp. 1376-1385
  22. Corona, G., Mannucci, E., Mansani, R., Petrone, L., Bartolini, M., Giommi, R., Mancini, M., Maggi, M., Aging and pathogenesis of erectile dysfunction (2004) Int J Impot Res, 16, pp. 395-402
  23. Isidori, A.M., Giannetta, E., Gianfrilli, D., Greco, E.A., Bonifacio, V., Aversa, A., Isidori, A., Lenzi, A., Effects of testosterone on sexual function in men: Results of a meta-analysis (2005) Clin Endocrinol (Oxf), 63, pp. 381-394
  24. Bolona, E.R., Uraga, M.V., Haddad, R.M., Tracz, M.J., Sideras, K., Kennedy, C.C., Caples, S.M., Montori, V.M., Testosterone use in men with sexual dysfunction: A systematic review and meta-analysis of randomized placebo-controlled trials (2007) Mayo Clin Proc, 82, pp. 20-28
  25. Snyder, P.J., Bhasin, S., Cunningham, G.R., Matsumoto, A.M., Stephens-Shields, A.J., Cauley, J.A., Gill, T.M., Ellenberg, S.S., Effects of testosterone treatment in older men (2016) N Engl J Med, 374, pp. 611-624
  26. Feldman, H.A., Longcope, C., Derby, C.A., Johannes, C.B., Araujo, A.B., Coviello, A.D., Bremner, W.J., Mc Kinlay, J.B., Age trends in the level of serum testosterone and other hormones in middle-ged men: Longitudinal results from the Massachusetts male aging study (2002) J Clin Endocrinol Metab, 87, pp. 589-598
  27. Rhoden, E.L., Teloken, C., Sogari, P.R., Souto, C.A., The relationship of serum testosterone to erectile function in normal aging men (2002) J Urol, 167, pp. 1745-1748
  28. Srinivas-Shankar, U., Roberts, S.A., Connolly, M.J., O’connell, M.D., Adams, J.E., Oldham, J.A., Wu, F.C., Effects of testosterone on muscle strength, physical function, body composition, and qual-ity of life in intermediate-frail and frail elderly men: A randomized, double-blind, placebo-controlled study (2010) J Clin Endocrinol Metab, 95, pp. 639-650
  29. Aversa, A., Bruzziches, R., Francomano, D., Rosano, G., Isidori, A.M., Lenzi, A., Spera, G., Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: Results from a 24-month, ran-domized, double-blind, placebo-controlled study (2010) J Sex Med, 7, pp. 3495-3503
  30. Heufelder, A.E., Saad, F., Bunck, M.C., Gooren, L., Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone (2009) J Androl, 30, pp. 726-733
  31. Cai, X., Tian, Y., Wu, T., Cao, C.X., Li, H., Wang, K.J., Metabolic effects of testosterone replacement therapy on hypogonadal men with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials (2014) Asian J Androl, 16, pp. 146-152
  32. Hackett, G., Cole, N., Bhartia, M., Kennedy, D., Raju, J., Wilkinson, P., Testosterone replacement therapy improves metabolic parameters in hypogonadal men with type 2 diabetes but not in men with coexisting depression: The BLAST study (2014) J Sex Med, 11, pp. 840-856
  33. Jones, T.H., Arver, S., Behre, H.M., Buvat, J., Meuleman, E., Moncada, I., Morales, A.M., Channer, K.S., Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (The TIMES2 study) (2011) Diabetes Care, 34, pp. 828-837
  34. Gianatti, E.J., Dupuis, P., Hoermann, R., Strauss, B.J., Wentworth, J.M., Zajac, J.D., Grossmann, M., Effect of testosterone treatment on glucose metabolism in men with type 2 diabetes: A random-ized controlled trial (2014) Diabetes Care, 37, pp. 2098-2107
  35. Traish, A.M., Haider, A., Doros, G., Saad, F., Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: An observational, long-term registry study (2014) Int J Clin Pract, 68, pp. 314-329
  36. Dhindsa, S., Ghanim, H., Batra, M., Kuhadiya, N.D., Abuaysheh, S., Sandhu, S., Green, K., Dandona, P., Insulin resistance and inflammation in hypogonadotropic hypogonadism and their reduction after testosterone replacement in men with type 2 diabetes (2016) Diabetes Care, 39, pp. 82-91
  37. Hackett, G., Heald, A.H., Sinclair, A., Jones, P.W., Strange, R.C., Ramachandran, S., Serum testoster-one, testosterone replacement therapy and all-cause mortality in men with type 2 diabetes: Retrospective consideration of the impact of PDE5 inhibitors and statins (2016) Int J Clin Pract, 70, pp. 244-253
  38. Reid, I.R., Serum testosterone levels during chronic glucocorticoid therapy (1987) Ann Intern Med, 106, pp. 639-640
  39. Crawford, B.A., Liu, P.Y., Kean, M.T., Bleasel, J.F., Handelsman, D.J., Randomized placebo-controlled trial of androgen effects on muscle and bone in men requiring long-term systemic glucocorti-coid treatment (2003) J Clin Endocrinol Metab, 88, pp. 3167-3176
  40. Reid, I.R., Wattie, D.J., Evans, M.C., Stapleton, J.P., Testosterone therapy in glucocorticoid-treated men (1996) Arch Intern Med, 156, pp. 1173-1177
  41. Reddy, R.G., Aung, T., Karavitaki, N., Wass, J.A., Opioid induced hypogonadism (2010) BMJ, 341, pp. c4462
  42. Huang, G., Travison, T., Maggio, M., Edwards, R.R., Basaria, S., Effects of testosterone replacement on metabolic and inflammatory markers in men with opioid-induced androgen deficiency (2016) Clin Endocrinol (Oxf), 85, p. 232
  43. Hembree, W.C., Cohen-Kettenis, P., Delemarre-Vande Waal, H.A., Gooren, L.J., Meyer, W.J., III, Spack, N.P., Tangpricha, V., Montori, V.M., Endocrine treatment of transsexual persons: An Endocrine Society clinical practice guideline (2009) J Clin Endocrinol Metab, 94, pp. 3132-3154
  44. Costa, E.M., Mendonca, B.B., Clinical management of transsexual subjects (2014) Arq Bras Endocrinol Metabol, 58 (2), pp. 188-196
  45. Pelusi, C., Costantino, A., Martelli, V., Lambertini, M., Bazzocchi, A., Ponti, F., Battista, G., Meriggiola, M.C., Effects of three different testosterone formulations in female-to-male transsexual persons (2014) J Sex Med, 11, pp. 3002-3011
  46. Wierman, M.E., Arlt, W., Basson, R., Davis, S.R., Miller, K.K., Murad, M.H., Rosner, W., Santoro, N., Androgen therapy in women: A reappraisal: An endocrine society clinical practice guideline (2014) J Clin Endocrinol Metab, 99, pp. 3489-3510
  47. Korenman, S.G., Morley, J.E., Mooradian, A.D., Davis, S.S., Kaiser, F.E., Silver, A.J., Viosca, S.P., Garza, D., Secondary hypogonadism in older men: Its relation to impotence (1990) J Clin Endocrinol Metab, 71, pp. 963-969
  48. Zarrouf, F.A., Artz, S., Griffith, J., Sirbu, C., Kommor, M., Testosterone and depression: Systematic review and meta-analysis (2009) J Psychiatr Pract, 15, pp. 289-305
  49. Cherrier, M.M., Matsumoto, A.M., Amory, J.K., Asthana, S., Bremner, W., Peskind, E.R., Raskind, M.A., Craft, S., Testosterone improves spatial memory in men with Alzheimer disease and mild cogni-tive impairment (2005) Neurology, 64, pp. 2063-2068
  50. Maki, P.M., Ernst, M., London, E.D., Mordecai, K.L., Perschler, P., Durso, S.C., Brandt, J., Resnick, S.M., Intramuscular testosterone treatment in elderly men: Evidence of memory decline and altered brain function (2007) J Clin Endocrinol Metab, 92, pp. 4107-4114
  51. Wang, C., Nieschlag, E., Swerdloff, R.S., Behre, H., Hellstrom, W.J., Gooren, L.J., ISA, ISSAM, EAU, EAA and ASA recommendations: Investigation, treatment and monitoring of late-onset hypogonadism in males (2009) Aging Male, 12, pp. 5-12
  52. Basaria, S., Coviello, A.D., Travison, T.G., Storer, T.W., Farwell, W.R., Jette, A.M., Eder, R., Bhasin, S., Adverse events associated with testosterone administration (2010) N Engl J Med, 363, pp. 109-122
  53. Sullivan, D.H., Roberson, P.K., Johnson, L.E., Bishara, O., Evans, W.J., Smith, E.S., Effects of muscle strength training and testosterone in frail elderly males (2005) Med Sci Sports Exerc, 37, pp. 1664-1672
  54. Coviello, A.D., Kaplan, B., Lakshman, K.M., Chen, T., Singh, A.B., Bhasin, S., Effects of graded doses of testosterone on erythropoiesis in healthy young and older men (2008) J Clin Endocrinol Metab, 93, pp. 914-919
  55. Bachman, E., Feng, R., Travison, T., Li, M., Olbina, G., Ostland, V., Ulloor, J., Bhasin, S., Testosterone suppresses hepcidin in men: A potential mecha-nism for testosterone-induced erythrocytosis (2010) J Clin Endocrinol Metab, 95, pp. 4743-4747
  56. Shahani, S., Braga-Basaria, M., Maggio, M., Basaria, S., Androgens and erythropoiesis: Past and present (2009) J Endocrinol Invest, 32, pp. 704-716
  57. Wu, F.C., Von Eckardstein, A., Androgens and coronary artery disease (2003) Endocr Rev, 24, pp. 183-217
  58. Haddad, R.M., Kennedy, C.C., Caples, S.M., Tracz, M.J., Bolona, E.R., Sideras, K., Uraga, M.V., Montori, V.M., Testosterone and cardiovascular risk in men: A systematic review and meta-analysis of randomized placebo-controlled trials (2007) Mayo Clin Proc, 82, pp. 29-39
  59. Fernandez-Balsells, M.M., Murad, M.H., Lane, M., Lampropulos, J.F., Albuquerque, F., Mullan, R.J., Agrwal, N., Montori, V.M., Clinical review 1: Adverse effects of testosterone therapy in adult men: A systematic review and meta-analysis (2010) J Clin Endocrinol Metab, 95, pp. 2560-2575
  60. Calof, O.M., Singh, A.B., Lee, M.L., Kenny, A.M., Urban, R.J., Tenover, J.L., Bhasin, S., Adverse events associated with testosterone replacement in middle-aged and older men: A meta-analysis of randomized, placebo-controlled trials (2005) J Gerontol a Biol Sci Med Sci, 60, pp. 1451-1457
  61. World Health Organization Task Force on methods for the regulation of male fertility (1990) Lancet, 336, pp. 955-959
  62. Gu, Y., Liang, X., Wu, W., Liu, M., Song, S., Cheng, L., Bo, L., Yao, K., Multicenter contraceptive efficacy trial of injectable testosterone undecanoate in Chinese men (2009) J Clin Endocrinol Metab, 94, pp. 1910-1915
  63. Layton, J.B., Li, D., Meier, C.R., Sharpless, J.L., Sturmer, T., Jick, S.S., Brookhart, M.A., Testosterone lab testing and initiation in the United Kingdom and the United States, 2000 to 2011 (2014) J Clin Endocrinol Metab, 99, pp. 835-842
  64. Zarotsky, V., Huang, M.Y., Carman, W., Morgentaler, A., Singhal, P.K., Coffin, D., Jones, T.H., Systematic literature review of the risk factors, comorbidities, and consequences of hypogonadism in men (2014) Andrology, 2, pp. 819-834

Coleções
Livros e Capítulos de Livros - HC/ICHC
Livros e Capítulos de Livros - LIM/42